Related references
Note: Only part of the references are listed.EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).
Christopher W. Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
Lorenzo Marconi et al.
CLINICAL GENITOURINARY CANCER (2021)
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
David A. Braun et al.
CANCER CELL (2021)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi et al.
CANCER CELL (2021)
Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy
Teele Kuusk et al.
CURRENT OPINION IN UROLOGY (2021)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Evolution of Renal Cell Carcinoma
Zayd Tippu et al.
EUROPEAN UROLOGY FOCUS (2021)
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Amin H. Nassar et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome
Dustin Baldridge et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)
THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells
Chuang Sun et al.
CANCER CELL (2020)
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
Yi Zhou et al.
IMMUNITY (2020)
T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis
Joanna Brzostek et al.
NATURE IMMUNOLOGY (2020)
Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Lucia Carril-Ajuria et al.
CANCERS (2020)
Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
Jee Soo Park et al.
CANCERS (2020)
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
Alessia Mennitto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
Anup Patel et al.
CLINICAL CANCER RESEARCH (2020)
Comprehensive Analysis of the Expression and Prognosis for TDO2 in Breast Cancer
Qiang Liu et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
The von Hippel-Lindau Tumor Suppressor Gene Implications and Therapeutic Opportunities
Roy Elias et al.
CANCER JOURNAL (2020)
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
Michele Carbone et al.
CANCER DISCOVERY (2020)
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
Robert J. Motzer et al.
NATURE MEDICINE (2020)
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer et al.
CANCER CELL (2020)
The Evolution of Angiogenic and Inflamed Tumors: The Renal Cancer Paradigm
James Brugarolas et al.
CANCER CELL (2020)
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells
Sanne Marlijn Janssen et al.
CELL DEATH DISCOVERY (2020)
STEAP1 Inhibits Breast Cancer Metastasis and I Associated With Epithelial-Mesenchymal Transition Procession
Jie Xie et al.
CLINICAL BREAST CANCER (2019)
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
Lisa Greene et al.
MOLECULAR CANCER RESEARCH (2019)
Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas
Jiali Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The adjuvant treatment of kidney cancer: a multidisciplinary outlook
Camillo Porta et al.
NATURE REVIEWS NEPHROLOGY (2019)
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Brian I. Rini et al.
LANCET (2019)
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
David N. Debruyne et al.
NATURE (2019)
Identifying gene function and module connections by the integration of multispecies expression compendia
Hao Li et al.
GENOME RESEARCH (2019)
Secretory Leukocyte Protease Inhibitor (SLPI)-A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study
Luisa Averdunk et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma
Chuanjie Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Daniel J. George et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma
Zhun Wang et al.
CLINICA CHIMICA ACTA (2018)
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
Daniel J. George et al.
CLINICAL CANCER RESEARCH (2018)
Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Brian I. Rini et al.
CLINICAL CANCER RESEARCH (2018)
Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
Amirali Salmasi et al.
EUROPEAN UROLOGY (2018)
Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials
Andrew T. Lenis et al.
JOURNAL OF UROLOGY (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
Chondroitin Sulfate Proteoglycan 4 and its Potential As an Antibody immunotherapy Target across Different Tumor Types
Kristina M. Ilieva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens
Joshua Pan et al.
CELL SYSTEMS (2018)
Kidney cancer: The next decade
Samra Turajlic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
Yuan-Yu Wu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing
Jie Wang et al.
CANCER CELL INTERNATIONAL (2018)
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J. Theisen et al.
SCIENCE (2018)
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
R. A. Figlin et al.
ANNALS OF ONCOLOGY (2018)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
PPIP5K1 interacts with the exocyst complex through a C-terminal intrinsically disordered domain and regulates cell motility
Gayane Machkalyan et al.
CELLULAR SIGNALLING (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
A. Ravaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Josephine F. Trott et al.
ONCOTARGET (2016)
IDO1 is an Integral Mediator of Inflammatory Neovascularization
Arpita Mondal et al.
EBIOMEDICINE (2016)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles
Julia Wilflingseder et al.
PLOS ONE (2014)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system
JS Lam et al.
JOURNAL OF UROLOGY (2005)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
Share Paper
